Practical Application of Indocyanine Green Camera in Laparoscopic Liver Surgery
NCT ID: NCT03579199
Last Updated: 2019-04-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
120 participants
INTERVENTIONAL
2019-03-18
2021-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The hypothesis of CAMVIC study is that the use of fluorescence imaging during laparoscopic hepatic surgery will allow to detect small subcapsular superficial lesions undetected by other diagnostic methods, which will improve the results of the oncologic treatment."
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Low Dose ICG for Biliary Tract and Tumor Imaging
NCT04942665
Application of ICG@HSA Complexes in Fluorescence Image-Guided Laparoscopic Anatomical Liver Resection
NCT06219096
Safety and Efficacy of Transarterial ICG Fluorescence-Guided Laparoscopic Anatomical Liver Resection
NCT07295275
A Pilot Study of Optical Molecular Imaging for Percutaneous Biopsy of Hepatocellular Carcinoma Using Indocyanine Green
NCT01962649
Assessment of Indocyanine Green as a Near-Infrared Fluorescent Contrast Agent for Image-guided Liver Surgery
NCT01738217
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* visual examination
* two-hand palpation
* intra-operative ultrasound.
During laparoscopic hepatic surgery it is not possible to palpate the liver thus peroperative examination of the liver surface is harder than during open surgery. Moreover per-operative ultrasound is not a reliable tool in order to explore liver surface. However the latest development of NIR cameras able to view ICG fluorescence could add a benefit in laparoscopic surgery in view of its capacity to detect superficial lesions, even those of small dimension."
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
exploration of abdominal cavity using a NIR/ICG camera
exploration of abdominal cavity and liver using a NIR/ICG camera
exploration of abdominal cavity and liver using a NIR/ICG camera
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
exploration of abdominal cavity and liver using a NIR/ICG camera
exploration of abdominal cavity and liver using a NIR/ICG camera
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients with liver tumor
* patient affiliated to french social security
Exclusion Criteria
* patient under guardianship or curator
* patient deprived of liberty by judicial or administrative decision or placed under judicial protection
* patient refusing to undergo the specific technique
* pregnant or lactating women
* patient with icteric cholestasis
* patient with contraindication to coelioscopy
* patient with known allergy to cyanines
* patient who must undergo staged hepatectomy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
FLUOPTICS
UNKNOWN
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hépato Biliaire de l'hopital Paul Brousse
Villejuif, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-A02807-46
Identifier Type: OTHER
Identifier Source: secondary_id
P170105J
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.